This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
这位ServiceNow分析师以看好的态度开始覆盖；以下是周二的三大启动对象
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
顶级华尔街分析师改变了他们对这些顶级股票的看法。有关所有分析师评级变动的完整信息，包括评级上调和下调，请查看我们的分析师评级页面。
- Raymond James analyst Robert Majek initiated coverage on ServiceNow, Inc. (NYSE:NOW) with an Outperform rating and announced a price target of $1200. ServiceNow shares closed at $1,088.26 on Monday. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert initiated coverage on AVITA Medical, Inc. (NASDAQ:RCEL) with a Buy rating and announced a price target of $25. AVITA Medical shares closed at $11.75 on Monday. See how other analysts view this stock.
- LifeSci Capital analyst Cory Jubinville initiated coverage on Mereo BioPharma Group (NASDAQ:MREO) with an Outperform rating and announced a price target of $10. Mereo BioPharma shares closed at $3.39 on Monday. See how other analysts view this stock.
- 雷蒙德·詹姆斯分析师罗伯特·马杰克对ServiceNow, Inc.（纽交所：NOW）进行了覆盖，给出了优于大盘的评级，并宣布目标价为1200美元。ServiceNow的股票在星期一收盘价为1088.26美元。看看其他分析师对这只股票的看法。
- D. Boral Capital分析师杰森·科尔伯特对AVITA Medical, Inc.（纳斯达克：RCEL）进行了覆盖，给予买入评级，并宣布目标价为25美元。AVITA Medical的股票在星期一收盘价为11.75美元。看看其他分析师对这只股票的看法。
- LifeSci Capital分析师科里·朱宾维尔对Mereo BioPharma Group（纳斯达克：MREO）进行了覆盖，给出了优于大盘的评级，并宣布目标价为10美元。Mereo BioPharma的股票在星期一收盘价为3.39美元。看看其他分析师对这只股票的看法。
Considering buying NOW stock? Here's what analysts think:
考虑购买NOW股票吗？以下是分析师的想法：
Read This Next:
接下来阅读：
- How To Earn $500 A Month From Qualcomm Stock
- 如何从高通股票中每月赚取500美元
资讯热榜
更新时间